Different Laboratory Abnormalities in COVID-19 Patients with Hypertension or Diabetes
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
---|---|
Enthalten in: |
Virologica Sinica - 35(2020), 6 vom: 30. Dez., Seite 853-856 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wu, Xiaojun [VerfasserIn] |
---|
Links: |
---|
Themen: |
9007-41-4 |
---|
Anmerkungen: |
Date Completed 05.02.2021 Date Revised 10.11.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s12250-020-00296-1 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM315678410 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM315678410 | ||
003 | DE-627 | ||
005 | 20231225155434.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s12250-020-00296-1 |2 doi | |
028 | 5 | 2 | |a pubmed24n1052.xml |
035 | |a (DE-627)NLM315678410 | ||
035 | |a (NLM)32997320 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wu, Xiaojun |e verfasserin |4 aut | |
245 | 1 | 0 | |a Different Laboratory Abnormalities in COVID-19 Patients with Hypertension or Diabetes |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.02.2021 | ||
500 | |a Date Revised 10.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 7 | |a Fibrin Fibrinogen Degradation Products |2 NLM | |
650 | 7 | |a fibrin fragment D |2 NLM | |
650 | 7 | |a C-Reactive Protein |2 NLM | |
650 | 7 | |a 9007-41-4 |2 NLM | |
650 | 7 | |a L-Lactate Dehydrogenase |2 NLM | |
650 | 7 | |a EC 1.1.1.27 |2 NLM | |
700 | 1 | |a Wang, Tong |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Yilu |e verfasserin |4 aut | |
700 | 1 | |a Liu, Xiaofan |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Hong |e verfasserin |4 aut | |
700 | 1 | |a Lu, Yang |e verfasserin |4 aut | |
700 | 1 | |a Tan, Weijun |e verfasserin |4 aut | |
700 | 1 | |a Yuan, Mingli |e verfasserin |4 aut | |
700 | 1 | |a Ding, Xuhong |e verfasserin |4 aut | |
700 | 1 | |a Zou, Jinjing |e verfasserin |4 aut | |
700 | 1 | |a Li, Ruiyun |e verfasserin |4 aut | |
700 | 1 | |a Liu, Hailing |e verfasserin |4 aut | |
700 | 1 | |a Ewing, Rob M |e verfasserin |4 aut | |
700 | 1 | |a Hu, Yi |e verfasserin |4 aut | |
700 | 1 | |a Nie, Hanxiang |e verfasserin |4 aut | |
700 | 1 | |a Wang, Yihua |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Virologica Sinica |d 2008 |g 35(2020), 6 vom: 30. Dez., Seite 853-856 |w (DE-627)NLM192619217 |x 1995-820X |7 nnns |
773 | 1 | 8 | |g volume:35 |g year:2020 |g number:6 |g day:30 |g month:12 |g pages:853-856 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s12250-020-00296-1 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 35 |j 2020 |e 6 |b 30 |c 12 |h 853-856 |